Doug Hampton

SurgiBox Inc, a technology startup based in Cambridge, Massachusetts, announces partnership with Ukrainian organizations to provide portable surgical kits (SurgiField Kits) doctors can use on battlefields to save lives

by

CAMBRIDGE, Mass., May 15, 2023 /PRNewswire/ — SurgiBox Inc., inventor of surgical kits that allow doctors to perform life-saving surgeries in the middle of war zones and under other extreme or hostile situations, has announced that it is collaborating with Ukrainian organizations to deliver the much-needed SurgiField Kits to train Ukrainian surgeons in advanced surgical … Read more

Older Americans Agree Smiling Could Make Them Feel Happier, But Many Are Held Back by a Self-Perpetuating Cycle of Poor Oral and Mental Health

by

Delta Dental’s first Senior Mental and Oral Health Survey reveals a harmful feedback loop between poor oral health and mouth pain, and depression, anxiety, and low self-image for Americans 50 and up. SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Mental health challenges contribute to the neglect of oral health care for many Americans 50 years … Read more

Global Home Health Hub Market to Garner High Returns by 2029

by

LONDON, May 15, 2023 /PRNewswire/ — The home health hub market is a rapidly growing sector that is revolutionizing the way healthcare is delivered to patients in their homes. Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time. These hubs offer a range … Read more

Sector to Reach $9 Billion by 2028 at a 3.96% CAGR

by

DUBLIN, May 15, 2023 /PRNewswire/ — The “Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028” report has been added to  ResearchAndMarkets.com’s offering. Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep … Read more

Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma

by

Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell carcinoma models SAN FRANCISCO, … Read more

Visgenx to present at the American Society of Gene and Cell Therapy 2023 Annual Meeting

by

Poster presentation covers data on VGX-0111, the Company’s gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leading cause of vision loss SAN DIEGO, May 15, 2023 /PRNewswire/ — Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced that the Company will … Read more

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research

by

LONDON, May 15, 2023 /PRNewswire/ — Acute repetitive seizures are an affliction that can strike fear into the hearts of those who suffer from them. These seizures are characterized by recurrent bouts of convulsions, muscle spasms, and loss of consciousness, all of which can happen multiple times in a short span of time. The condition can … Read more

Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health

by

Innovators Iyah Romm, Co-Founder and former CEO of Cityblock Health, and Ryan Watts, Co-Founder and CEO of Denali Therapeutics, poised to Help Rippl Transform care for seniors with neurocognitive challenges SEATTLE, May 15, 2023 /PRNewswire/ — Rippl, a new kind of behavioral health company focused on dramatically expanding access to high quality, wrap-around care for … Read more

Report Forecasts Promising Future for Alzheimer’s Disease Market with New Therapeutic Approaches

by

LONDON, May 15, 2023 /PRNewswire/ — Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions of people worldwide. As the population ages, the incidence of Alzheimer’s disease is expected to rise, creating a growing need for effective treatments. This presents a significant opportunity for the development of innovative therapies that can improve the lives of … Read more

NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours

by

Collaboration agreement strengthens 61Cu-supply chain capabilities for clinical development in North America BASEL, Switzerland and BOCA RATON, Fla., May 15, 2023 /PRNewswire/ — NUCLIDIUM and PharmaLogic Holdings today announced that they have entered into a strategic collaboration agreement for the production and clinical supply of 61Cu in the United States to accelerate the development of … Read more